Intrexon to Acquire Remaining Stake in Exemplar Genetics
Intrexon Collaborators Obtain Access to Premier Pipeline of Large Animal Research Models and Custom Animal Development
Visit EG at Society of Toxicology 54TH Annual Meeting and ToxExpo March 22–26, 2015
Society of Toxicology 54TH Annual Meeting and ToxExpo San Diego Convention Center San Diego, CA March 22–26, 2015 Booth 1013 Conference website
Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease 2015 Scientific Session this May
Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease 2015 Scientific Session May 7 - 9, 2015 Hilton San Francisco Union Square San Francisco, CA Conference website
EG to exhibit at 2015 BIO International Convention June 2015
June 15-18, 2015 Philadelphia, PA Booth 3849 Conference website.
ExeGen LDLR MiniSwine
Features consistent, stable hypercholesterolemia that can be further modulated by diet. Predictable, progressive atherosclerosis that manifests on an accelerated timeline. Atherosclerotic lesion formation in the aorta and coronary arteries that model key pathophysiological aspects of human atherosclerosis. Defined Yucatan miniature swine genetics that offers greater consistency.
A rare opportunity arises for an family fighting a rare disease
“You could have picked me up off of the floor. Out of 50,000 people at a conference, the chances of meeting someone researching A-T is very, very rare. Dr. Swart never could have imagined that I was connected to the organization or a mother of three A-T adults. I told him that maybe I could help,” Amy said, laughing.
Discovery drives the human race to new heights each day.
Explorers in all fields have made our lives and world better through their courage to venture into new frontiers and beyond. Yet, their ability to discover has always relied on the proper vehicle to propel them from theory to reality. At Exemplar Genetics, we enable discovery by providing the vehicle to break new ground on the medical research frontier.
Until now, researchers have lacked animal models that faithfully represent human diseases. As a result, a sizeable barrier has blocked progress in the discovery of human disease mechanisms; novel diagnostics, procedures, devices, prevention strategies and therapeutics; and the ability to predict in humans the efficacy of those next-generation procedures, devices, and therapeutics.